Position in SKYE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$36
-$12 QoQ
Shares Held
52
-34.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 3 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SKYE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Waterhouse Canada Inc. holds $97,600,022 across 91 Biotechnology names. SKYE ranks #80 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
9,568,149 | $75,109,969 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,646 | $6,778,377 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
19,625 | $6,203,266 | |
| 4 | RPRX |
Royalty Pharma plc
|
81,697 | $4,580,750 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
36,694 | $1,726,085 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
1,975 | $562,815 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,825 | $549,379 | |
| 8 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
79,607 | $526,202 |
All Filings in SKYE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36 | 52 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $48 | 79 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $18 | 25 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $98 | 25 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $104 | 25 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $39 | 25 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $70 | 25 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7 | 2 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $16 | 2 | Shares | Defined | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||